Search

Your search keyword '"Delaforge, Marcel"' showing total 373 results

Search Constraints

Start Over You searched for: Author "Delaforge, Marcel" Remove constraint Author: "Delaforge, Marcel"
373 results on '"Delaforge, Marcel"'

Search Results

2. Data from Phostine PST3.1a Targets MGAT5 and Inhibits Glioblastoma-Initiating Cell Invasiveness and Proliferation

3. Neurosphere formation_PST3.1a-treated from Phostine PST3.1a Targets MGAT5 and Inhibits Glioblastoma-Initiating Cell Invasiveness and Proliferation

4. Supplementary figures 1 to 6 from Phostine PST3.1a Targets MGAT5 and Inhibits Glioblastoma-Initiating Cell Invasiveness and Proliferation

5. Neurosphere formation_control from Phostine PST3.1a Targets MGAT5 and Inhibits Glioblastoma-Initiating Cell Invasiveness and Proliferation

7. Structure-Activity Relationships of Cyclotetrapeptides: Interaction of Tentoxin Derivatives with Three Membrane Proteins

19. Verruculogen associated with Aspergillus fumigatus hyphae and conidia modifies the electrophysiological properties of human nasal epithelial cells

24. Phostine PST3.1a Targets MGAT5 and Inhibits Glioblastoma-Initiating Cell Invasiveness and Proliferation

25. Hétérocycles phosphorés analogues de sucres à activité antimétastatique

26. Effet antimétastatique des phostines. (2013)

27. Microbiological evaluation of ten French archives and link to occupational symptoms

28. PULMONARY METABOLISM OF STERIGMATOCYSTIN AND METHOXY-STERIGMATOCYSTIN STUDIES: CONTRIBUTION OF UNIFORMLY C-13-ENRICHED STERIGMATOCYSTIN

29. Caractérisation des micro-organismes dans les taches de foxing des papiers :nouvelles approches analytiques

30. Contribution of uniformly 13C‐enriched sterigmatocystin to thestudy of its pulmonary metabolism

31. Modeling of cytochrome P450 (cyt P450, CYP) channels

32. Ecrins à bijoux contaminés par Aspergillus oryzae et risques professionnels

40. Production and use of mycotoxins uniformeously enriched with stable isotopes for their dosage in biological samples 1Production of enriched biomass

41. Production and use of mycotoxins uniformeously enriched with stable isotopes for their dosage in biological samples 3) Tools for pharmacokinetics and as Internal standard

43. Possible toxicity of clinical isolates of Candida albicans

46. Possible toxicity of clinical isolates of C. albicans

48. Safety and pharmacokinetics of the CIME combination of drugs and their metabolites after a single oral dosing in healthy volunteers

49. Les antibiotiques macrolides : Inbihition suicide du P450 et optimisation thérapeutique

Catalog

Books, media, physical & digital resources